
The short answer
Yes. MK-4 and MK-7 are both vitamin K2, but they differ in side chain length, food sources and time in the blood. After the same 420 μg single dose, MK-7 stayed detectable in serum for up to 48 hours, while MK-4 was not detectable at any point.1 MK-7 was researched in micrograms; MK-4 for bones in milligrams, as a medicine.7
What is the difference between MK-4 and MK-7?
Vitamin K2 is not one substance but a family of menaquinones, each named MK-n after the number of units in its side chain. MK-4 has 4 isoprenoid units and MK-7 has 7. Both do the same basic job as vitamin K, acting as a cofactor for the carboxylation of vitamin K-dependent proteins. Vitamin K1, by contrast, is phylloquinone, the plant form.
Is vitamin K2 one substance or a family?
A family. Each member shares the same active head group and differs only in side chain length, which changes where it comes from and how long it stays in the body. When a label says K2 (MK-7) or K2 (MK-4), it names one member, and the members behave differently in the blood, as the single dose study below shows.1

Where do MK-4 and MK-7 come from in food?
MK-4 comes mainly from animal foods such as meat, liver, butter, egg yolk and dairy, while MK-7 comes from fermented foods, above all natto, the Japanese fermented soybean dish. A US analysis of 128 meat items, 24 dairy and egg items and 169 fast foods found no single item in these categories was a rich source of any one form of vitamin K.2
Why does natto appear in so many MK-7 studies?
Because natto delivers a lot of K2 in one meal. In a test with 6 healthy men, a meal of 200 g natto (3.1 μmol K2) and 400 g spinach (3.5 μmol K1) raised circulating K2 to about 10 times the K1 level.3 Serum peaks came at 6 hours for the vitamins eaten in food and at 4 hours for pure, dissolved K1.3 The MK-7 used in supplement research is often natto-derived, as the title of one of the main comparison studies states.5
Does your body make MK-4 itself?
Yes, animal research shows tissues can build MK-4 from other vitamin K forms. In rats, oral phylloquinone is converted to menadione in the intestine, delivered to tissues and converted to menaquinone-4 by the enzyme UBIAD1.4 This is tissue conversion, demonstrated in animals; how much it contributes to human MK-4 status is not settled.
How long do MK-4 and MK-7 stay in your blood?
After a single 420 μg dose taken with breakfast by healthy Japanese women, MK-7 peaked in serum at 6 hours and was still detectable at 48 hours, while MK-4 was not detectable in serum at any time point.1 With 7 days of 60 μg daily doses, MK-7 serum levels rose significantly in all subjects and MK-4 did not increase serum levels at all.1
| Measure | MK-4 | MK-7 |
|---|---|---|
| Single dose in study | 420 μg (945 nmol) | 420 μg (647 nmol) |
| Detectable in serum | No, at any time point | Yes, up to 48 h |
| Repeated dose, 7 days | 60 μg, no serum increase | 60 μg, significant increase in all subjects |
| Typical study dose | Milligram doses as medicine | Microgram doses as supplement |
Another supplement study in healthy volunteers found peak serum concentrations of both K1 and MK-7 at 4 hours after intake, with MK-7 building up to 7- to 8-fold higher levels than K1 during prolonged intake because of its very long half-life.5
Does a longer half-life make MK-7 the better form?
Not proven. A longer half-life means MK-7 stays in the blood longer and builds up with daily intake.5 Staying in the blood longer is not the same as a better result for bones or anything else. The direct comparisons are few, and they measured blood levels, not outcomes.1 No study has shown a winner, and we do not declare one.
Why do MK-4 and MK-7 studies use such different doses?
Because the two forms were studied for different purposes. MK-7 was studied as a food supplement in microgram doses, for example 180 μg a day for 3 years.6 MK-4 was studied as a medicine called menatetrenone, in people with osteoporosis, in milligram doses: one 6-month randomized study in 109 postmenopausal women with osteoporosis gave 56 of them 45 mg of menatetrenone a day and 53 controls 133.8 mg of elemental calcium a day.7
A word of caution on that literature: a meta-analysis of menatetrenone against fractures in patients with neurological diseases was retracted because two of its three included trials had been retracted for fabricated data.8 Read older menatetrenone fracture results with that in mind. A review of vitamin K in postmenopausal women described MK-4 as appearing safe at doses as high as 45 mg a day.9 That is a statement about a medicine in trials, and it is no guide to a supplement dose.
What did trials with each form actually measure?
Mostly blood markers and bone density, not hard outcomes, and rarely head-to-head. The table compares representative trials.
| Form | Dose | Duration | Who | Measured |
|---|---|---|---|---|
| MK-4 and MK-7 | 420 μg single, 60 μg for 7 days | Single dose; 7 days | Healthy Japanese women | Serum MK-4 and MK-71 |
| MK-7 | 180 μg/day | 3 years, n = 244 | Healthy postmenopausal women | BMC and BMD by DXA at spine and femoral neck, bone strength6 |
| MK-7 | 10, 20, 45 μg/day | Daily, on top of acenocoumarol | Healthy volunteers on acenocoumarol | INR, clotting markers10 |
| MK-4 | 45 mg/day | 6 months, n = 109 | Postmenopausal osteoporosis patients | Osteocalcin and bone turnover markers7 |
In the 3-year MK-7 trial, the team followed 244 healthy postmenopausal women taking 180 μg of MK-7 a day or a placebo, and measured bone mineral content and density by DXA scan at the lumbar spine, femoral neck and total hip.6 In the menatetrenone trial, the treated group had significantly lower undercarboxylated osteocalcin at 1 month (P < 0.001) and higher carboxylated osteocalcin (P = 0.018), but also higher urinary NTX, a marker of bone resorption, after 6 months.7 These are research results in specific groups. For a food supplement, the only authorised wording on this subject is that vitamin K contributes to the maintenance of normal bones.
What may an EU label say about vitamin K2?
Only two authorised claims exist for vitamin K in the EU, and they name vitamin K in general, not K2, MK-7 or MK-4: vitamin K contributes to normal blood clotting, and vitamin K contributes to the maintenance of normal bones. There is no authorised claim specific to K2, MK-7 or MK-4, so a K2 bottle that promises more than these two sentences goes beyond what EU law authorises.
The nutrient reference value for vitamin K is 75 μg. EFSA set its adequate intake of 1 μg phylloquinone per kg body weight per day, which means 70 μg per day for all adults, for phylloquinone only, because it judged the evidence on occurrence, absorption, function and body content of menaquinones insufficient.11
Can you compare a K2 dose with EFSA's 70 μg?
Not directly. EFSA's 70 μg a day for adults is an adequate intake for phylloquinone, vitamin K1, and the panel set no figure for MK-4 or MK-7 because it judged the evidence on menaquinones insufficient.11 The 75 μg printed on labels is the nutrient reference value for vitamin K in general under EU labelling law. A percentage of 75 μg next to MK-7 therefore compares it with a reference for vitamin K as a whole, and not with a requirement for K2.
Why does vitamin K2 matter if you take blood thinners?
Because microgram doses of MK-7 measurably affect anticoagulation. In healthy volunteers who took the anticoagulant acenocoumarol, 45 μg of MK-7 per day lowered group mean INR and uncarboxylated factor II by about 40%. Even 10 and 20 μg per day caused clinically relevant INR lowering in at least 40% and 60% of subjects respectively.10 Another paper warned that preparations supplying 50 μg per day or more of MK-7 may interfere with oral anticoagulant treatment.5
Our product warning says it plainly: if you take anticoagulants (blood thinners), consult your physician before use. The dose-response data above are the reason for that line. Talk to your doctor; this article is not medical advice.

What should a K2 label tell you?
Three things: the exact form (MK-4 or MK-7 or another menaquinone), the amount in μg per serving, and how often to take it. A label that only says vitamin K2 leaves you guessing on all three. Isomer detail is a further step: one analysis of supplement pills found all-trans MK-7 content between 5.5 and 49 μg per pill, with cis/trans isomers exceeding the all-trans content by up to 3.7 times.12
Applied to our own Vitamin D3 + K2 Drops: each 0.25 ml serving gives 120 μg of vitamin K2 named as MK-7, taken every 3 days, which averages, by our calculation, 40 μg of MK-7 per day. We state the form and the amount; we do not state an isomer split, and we will not claim one. How vitamin D and vitamin K are combined in one product is covered in our article on D3 and K2.
Frequently Asked Questions
Is MK-4 real vitamin K2?
Yes. MK-4 and MK-7 are both menaquinones, both vitamin K2, with the same core function as vitamin K. They are family members, not different vitamins.
Why does one K2 bottle list micrograms and another milligrams?
Because the two forms come from different research. MK-7 was studied at microgram doses, such as 180 μg a day for 3 years in healthy postmenopausal women.6 MK-4 was studied for bones as menatetrenone, a medicine, at 45 mg a day in people with osteoporosis.7 The unit tells you which kind of research a dose comes from.
Is MK-7 better absorbed than MK-4?
After a single 420 μg dose, MK-7 was detectable in serum up to 48 hours and MK-4 was not detectable at all. That is a clear difference in blood presence at nutritional doses, though not proof of a better clinical outcome.1
Can I get MK-7 from food?
Yes, mainly from natto. After a 200 g natto meal, circulating K2 was about 10 times higher than K1 after 400 g of spinach in the same volunteers.3
Does vitamin K2 have its own EU health claim?
No. The EU authorises claims for vitamin K only: normal blood clotting and maintenance of normal bones. No claim exists for K2, MK-7 or MK-4 specifically.
Is the MK-4 in meat and eggs a good source?
A US analysis of meat, dairy, eggs and fast foods found no single item was a rich source of any vitamin K form.2
The Bottom Line
MK-4 and MK-7 are both real vitamin K2. MK-7 circulates far longer at microgram doses and comes from fermented foods; MK-4 comes from animal foods and was trialled as a milligram medicine. Neither has a specific EU claim; both fall under the two authorised vitamin K claims for normal blood clotting and maintenance of normal bones. If you take blood thinners, talk to your doctor first; microgram doses of MK-7 measurably affect INR.10 Our Vitamin D3 + K2 Drops state the form, MK-7, and the amount, 120 μg per 0.25 ml every 3 days; the reason for that schedule is explained in our dosing article.
Sources
- Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women, Nutrition journal, 2012
- Vitamin K contents of meat, dairy, and fast food in the U.S. diet, Journal of Agricultural and Food Chemistry, 2006
- Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations, Haemostasis, 2000
- Menadione (vitamin K3) is a catabolic product of oral phylloquinone (vitamin K1) in the intestine and a circulating precursor of tissue menaquinone-4 (vitamin K2) in rats, The Journal of Biological Chemistry, 2013
- Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7, Blood, 2007
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women, Osteoporosis International, 2013
- Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis, Journal of Bone and Mineral Metabolism, 2009
- Retraction Note to: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases, Clinical Drug Investigation, 2018
- Effects of vitamin K in postmenopausal women: mini review, Maturitas, 2014
- Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment, Journal of Thrombosis and Haemostasis, 2013
- Dietary reference values for vitamin K, EFSA Journal, 2017
- Identification of cis/trans isomers of menaquinone-7 in food as exemplified by dietary supplements, Food Chemistry, 2018


